The company was founded in 2006, with more than $1 billion in equity, by Robert Clements and his son John Clements, two long-time insurance investors.[7][8][9]
Ironshore named Kevin Kelley as
CEO in December 2008.[10][11][12][13] Kelley had been the longtime CEO of
Lexington Insurance, which became the largest excess and surplus lines insurer in the world under his leadership.[14] Shaun Kelly resigned as president and
Chief Operating Officer of Lexington and was appointed chief executive officer of U.S. Operations for Ironshore.[15] During 2015, Ironshore acquired Dubai-based MGA, Visionary underwriting Agency Ltd, a Lloyd's Coverholders founded in 2010 by David Austin.[citation needed]
Operations
The company's product lines include
Aviation, Environmental,[16][17] IronBuilt, IronHealth,[18] IronPro, Marine Re, Personal Lines,[19]Political Risk,[20] Ironshore Programs,[21] and U.S. Property and Specialty Casualty.[22]
The Ironshore group of companies is rated A (Excellent) by
A.M. Best with a Financial Size Category of XIV. Ironshore’s Pembroke Syndicate 4000 operates within Lloyd’s with a market rating of A (Excellent) from A.M. Best and A+ from both
Standard and Poor’s and
Fitch Group. A.M. Best announced in 2012 a revised rating outlook to "Positive" for Ironshore and its subsidiaries.[23][24]
On 29 June 2020, Ironshore Pharmaceuticals Inc. ('Ironshore'), a wholly owned affiliate of Highland Therapeutics Inc., confirmed the publication in the Field of Clinical Psychopharmacology of an original paper outlining a concept that could promote the dose optimisation of JORNAY PM® (methylphenidate HCl) extended-release capsules CII. In August 2018, the US Food and Drug Administration (FDA) licensed JORNAY PM to treat ADHD in children 6 years of age and older.[25]